Northern Trust
ANRO icon

Northern Trust’s Alto Neuroscience ANRO Stock Holding History

Northern Trust’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
632,701
+159,298
+34% +$3.68M ﹤0.01% 1902
2026
Q1 		$10.6M Sell
473,403
-970
-0.2% -$18K ﹤0.01% 2037
2025
Q4 		$8.44M Buy
474,373
+13,088
+3% +$165K ﹤0.01% 2173
2025
Q3 		$1.85M Sell
461,285
-2,059
-0.4% -$6.83K ﹤0.01% 3074
2025
Q2 		$1.02M Sell
463,344
-125,935
-21% -$300K ﹤0.01% 3386
2025
Q1 		$1.27M Buy
589,279
+2,144
+0.4% +$7.67K ﹤0.01% 3171
2024
Q4 		$2.48M Buy
587,135
+390,190
+198% +$2.44M ﹤0.01% 2901
2024
Q3 		$2.25M Buy
196,945
+175,911
+836% +$2.15M ﹤0.01% 2928
2024
Q2 		$225K Buy
21,034
+4,647
+28% +$60.5K ﹤0.01% 3829
2024
Q1 		$252K Buy
+16,387
New +$256K ﹤0.01% 3815

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Northern Trust's ANRO Position: Q2 2026 in Review

Northern Trust increased its Alto Neuroscience (ANRO) stake by 34% in Q2 2026, buying an estimated $3.68M and bringing the position to 632,701 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Northern Trust first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Northern Trust held 632,701 shares of Alto Neuroscience worth $16.7M as of Q2 2026.
  • Northern Trust bought 159,298 Alto Neuroscience shares in Q2 2026, an estimated $3.68M.
  • Alto Neuroscience made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1902 holding.
  • Northern Trust first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.